Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Return on Sales (2016 - 2025)

Historic Return on Sales for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to 0.03%.

  • Surgery Partners' Return on Sales rose 200.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.0% for FY2024, which is 500.0% down from last year.
  • Surgery Partners' Return on Sales amounted to 0.03% in Q3 2025, which was up 200.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Return on Sales registered a high of 0.09% during Q2 2023, and its lowest value of 0.05% during Q4 2024.
  • Its 5-year average for Return on Sales is 0.03%, with a median of 0.03% in 2025.
  • As far as peak fluctuations go, Surgery Partners' Return on Sales soared by 800bps in 2021, and later crashed by -1200bps in 2024.
  • Over the past 5 years, Surgery Partners' Return on Sales (Quarter) stood at 0.07% in 2021, then plummeted by -53bps to 0.03% in 2022, then soared by 93bps to 0.06% in 2023, then tumbled by -185bps to 0.05% in 2024, then skyrocketed by 157bps to 0.03% in 2025.
  • Its Return on Sales was 0.03% in Q3 2025, compared to 0.05% in Q2 2025 and 0.0% in Q1 2025.